Copyright
©2010 Baishideng.
World J Gastroenterol. Feb 28, 2010; 16(8): 982-986
Published online Feb 28, 2010. doi: 10.3748/wjg.v16.i8.982
Published online Feb 28, 2010. doi: 10.3748/wjg.v16.i8.982
n (%) | |
Out of the total sample (n = 286) | |
Treatment indications | 35 (12) |
Claimed as using PPI for SUP indication | 251 (88) |
Classification of patients claimed as using PPI for SUP indication (n = 251) | |
Meeting criteria for SUP indication | 43 (17) |
Meeting criteria for NSAIDs-induced prophylaxis | 35 (14) |
Age ≥ 65 yr + NSAIDs | 12 (5) |
NSAIDS + antithrombotics | 23 (9) |
NSAIDS + corticosteroids | 17 (7) |
Unjustified prophylactic use | 173 (69) |
Age ≥ 65 yr | 81 (32) |
Age ≥ 65 yr + LMWH | 55 (22) |
Age ≥ 65 yr + antiplatelets | 60 (24) |
Age ≥ 65 yr + corticosteroids | 25 (10) |
Others | 90 (36) |
- Citation: Nasser SC, Nassif JG, Dimassi HI. Clinical and cost impact of intravenous proton pump inhibitor use in non-ICU patients. World J Gastroenterol 2010; 16(8): 982-986
- URL: https://www.wjgnet.com/1007-9327/full/v16/i8/982.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i8.982